Non-conversion of sputum culture among patients with smear positive pulmonary tuberculosis in Cameroon: A prospective cohort study

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Pefura Yone, Eric W ^a,b   Kengne, André P ^c   Kuaban, Christopher ^a,b,d  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b Yaounde Jamot Hospital   (Cameroon)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^d UNIVERSITY OF BAMENDA   (Cameroon)

Author keywords

Cameroon; Culture conversion; Mycobacterium tuberculosis; Outcome

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADULT; ARTICLE; CAMEROON; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DRUG SENSITIVITY; FEMALE; HEMOPTYSIS; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PATIENT MONITORING; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SMOKING; SPUTUM CULTURE; SPUTUM EXAMINATION; SPUTUM SMEAR; TREATMENT DURATION; TREATMENT FAILURE; ADOLESCENT; ANTIBIOTIC RESISTANCE; BACTERIUM CULTURE; DIRECTLY OBSERVED THERAPY; DRUG TREATMENT FAILURE; NONHUMAN; OUTCOME ASSESSMENT;

ADULT; ANTITUBERCULAR AGENTS; CAMEROON; COHORT STUDIES; FEMALE; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 84899157404     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-138     Document Type: Article

References (14)

1. World Health Organisation Global tuberculosis report 2013, [http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf], World Health Organisation.
2. National Tuberculosis Control Program Manual for health personnel 2006, Yaounde: Ministry of public health of Cameroon, National Tuberculosis Control Program.
3. World Health Organisation Treatment of tuberculosis guidelines 2009, Geneva: World Health Organization, World Health Organisation.
4. Fitzwater SP, Caviedes L, Gilman RH, Coronel J, LaChira D, Salazar C, Saravia JC, Reddy K, Friedland JS, Moore DA. Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy. Clin Infect Dis 2010, 51:371-378. 10.1086/655127, 20624064.
5. Salaniponi FM, Christensen JJ, Gausi F, Kwanjana JJ, Harries AD. Sputum smear status at two months and subsequent treatment outcome in new patients with smear-positive pulmonary tuberculosis. Int J Tuberc Lung Dis 1999, 3:1047-1048.
6. Kuaban C, Bame R, Mouangue L, Djella S, Yomgni C. Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaounde, Cameroon. East Afr Med J 2009, 86:219-225.
7. Su WJ, Feng JY, Chiu YC, Huang SF, Lee YC. Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis. Eur Resp J 2010, 37:376-383.
8. Ait-Khaled N, Alarcón E, Armengol R. Prise en charge de la tuberculose. Guide des éléments essentiels pour une bonne pratique. (Sixième édition). Union Internationale Contre la Tuberculose et les Maladies Respiratorires 2010,
9. Canetti G, Rist N, Grosset J. Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation. Rev Tuberc Pneumol (Paris) 1963, 27:217-272.
10. Ramarokoto H, Randriamiharisoa H, Rakotoarisaonina A, Rasolovavalona T, Rasolofo V, Chanteau S, Ralamboson M, Cauchoix B, Rakotondramarina D. Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment. Int J Tuberc Lung Dis 2002, 6:909-912.
11. Pefura Yone EW, Kengne AP, Kuaban C. Incidence, time and determinants of tuberculosis treatment default in Yaounde, Cameroon: a retrospective hospital register-based cohort study. BMJ Open 2011, 1:e000289. 3225586, 22116091.
12. Maciel EL, Brioschi AP, Peres RL, Guidoni LM, Ribeiro FK, Hadad DJ, Vinhas SA, Zandonade E, Palaci M, Dietze R, Johnson JL. Smoking and 2-month culture conversion during anti-tuberculosis treatment. Int J Tuberc Lung Dis 2013, 17:225-228. 10.5588/ijtld.12.0426, 23317958.
13. Gullon Blanco JA, Suarez Toste I, Lecuona Fernandez M, Galindo Morales R, Fernandez Alvarez R, Rubinos Cuadrado G, Medina Gonzalvez A, Gonzalez Martin IJ. Tobacco smoking and sputum smear conversion in pulmonary tuberculosis. Med Clin (Barc) 2007, 128:565-568. 10.1157/13101612, 17462193.
14. Assam-Assam J-P, Penlap VB, Cho-Ngwa F, Tedom J-C, Ane-Anyangwe I, Titanji VP. Mycobacterium tuberculosis complex drug resistance pattern and identification of species causing tuberculosis in the West and Centre regions of Cameroon. BMC Infect Dis 2011, 11:94. 10.1186/1471-2334-11-94, 3090333, 21496268.